These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 184570)

  • 1. [Extrapyramidal and presenile dementia. Relation between symptoms of dementia and cerebral transmitters, particularly dopamine].
    Kristensen V
    Ugeskr Laeger; 1976 Aug; 138(34):2047-50. PubMed ID: 184570
    [No Abstract]   [Full Text] [Related]  

  • 2. Problems in the contemporary treatment of parkinsonism.
    Eadie MJ
    Med J Aust; 1985 Jan; 142(2):113-7. PubMed ID: 2981393
    [No Abstract]   [Full Text] [Related]  

  • 3. [Biochemical bases of Parkinson disease].
    Colucci d'Amato C; Puccini A; Cristillo A; Vizioli R
    Recenti Prog Med; 1984 Oct; 75(10):889-901. PubMed ID: 6151219
    [No Abstract]   [Full Text] [Related]  

  • 4. Biochemical substrates of mental disturbances in Parkinson's disease.
    Agid Y; Ruberg M; Dubois B; Javoy-Agid F
    Adv Neurol; 1984; 40():211-8. PubMed ID: 6695597
    [No Abstract]   [Full Text] [Related]  

  • 5. Drug-induced changes in brain dopamine and their relation to parkinsonism.
    Vogt M
    Sci Basis Med Annu Rev; 1970; ():276-91. PubMed ID: 4319923
    [No Abstract]   [Full Text] [Related]  

  • 6. [Abnormal neurotransmission in neurological diseases (author's transl)].
    Toru M
    Tanpakushitsu Kakusan Koso; 1979; 24(2):150-9. PubMed ID: 35816
    [No Abstract]   [Full Text] [Related]  

  • 7. [Influencing of Parkinson's syndrome via intervention in the dopamine metabolism].
    Korten JJ; van Rossum JM
    Ned Tijdschr Geneeskd; 1973 Feb; 117(8):296-305. PubMed ID: 4350090
    [No Abstract]   [Full Text] [Related]  

  • 8. [L-dopa treatment in parkinsonism. Biochemical basis (author's transl)].
    Bieniowa A; Kolasa M; Reichowa J
    Przegl Lek; 1976; 33(4):463-7. PubMed ID: 1273343
    [No Abstract]   [Full Text] [Related]  

  • 9. Levodopa treatment of presenile dementia.
    Kristensen V; Olsen M; Theilgaard A
    Acta Psychiatr Scand; 1977 Jan; 55(1):41-51. PubMed ID: 842382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Current perspectives in the treatment of Parkinson disease].
    Rodríguez M; Palarea MD; Castro R; Pérez J; Arévalo R
    Med Clin (Barc); 1985 Nov; 85(15):633-40. PubMed ID: 2867259
    [No Abstract]   [Full Text] [Related]  

  • 11. Biochemical neuropathology of Parkinson's disease.
    Javoy-Agid F; Ruberg M; Taquet H; Bokobza B; Agid Y; Gaspar P; Berger B; N'Guyen-Legros J; Alvarez C; Gray F
    Adv Neurol; 1984; 40():189-98. PubMed ID: 6695594
    [No Abstract]   [Full Text] [Related]  

  • 12. [The role of brain dopamine].
    Rybakowski J
    Psychiatr Pol; 1972; 6(3):341-4. PubMed ID: 4560234
    [No Abstract]   [Full Text] [Related]  

  • 13. [L-threo-DOPS therapy and parkinsonism].
    Narabayashi H
    No To Shinkei; 1986 Jan; 38(1):60-2. PubMed ID: 3083844
    [No Abstract]   [Full Text] [Related]  

  • 14. Dopaminergic mechanisms in patients with extrapyramidal disease.
    Chase TN; Shoulson I
    Adv Neurol; 1975; 9():359-66. PubMed ID: 1146660
    [No Abstract]   [Full Text] [Related]  

  • 15. [Thoughts on the neurobiological aspects of Parkinson syndrome].
    Sommer H
    Psychiatr Neurol Med Psychol (Leipz); 1986 Feb; 38(2):86-90. PubMed ID: 3010357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Parkinson's disease. Dopamine may sustain toxic protein.
    Couzin J
    Science; 2001 Nov; 294(5545):1257-8. PubMed ID: 11701896
    [No Abstract]   [Full Text] [Related]  

  • 17. Dopamine neurotransmission and brain function.
    Ungerstedt U; Herrera-Marschitz M; Zetterström T
    Prog Brain Res; 1982; 55():41-9. PubMed ID: 6298865
    [No Abstract]   [Full Text] [Related]  

  • 18. Dopaminergic nervous transmission in Parkinson's disease.
    Rinne UK; Sonninen V; Riekkinen P; Laaksonen H
    Med Biol; 1974 Jun; 52(3):208-17. PubMed ID: 4371255
    [No Abstract]   [Full Text] [Related]  

  • 19. Reevaluation of levodopa therapy for the treatment of advanced Parkinson's disease.
    Yokochi M
    Parkinsonism Relat Disord; 2009 Jan; 15 Suppl 1():S25-30. PubMed ID: 19131038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Updates in practical neurology--I. The principles of modern levodopa therapy in Parkinson's disease].
    Klivényi P; Vécsei L
    Ideggyogy Sz; 2007 Jan; 60(1-2):61-4. PubMed ID: 17432097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.